Arrowhead Pharmaceuticals (ARWR) Share-based Compensation (IS) (2011 - 2017)
Arrowhead Pharmaceuticals' Share-based Compensation (IS) came in at $2.09 million for fiscal Q1 2018 (quarter ended Dec 31, 2017), down 13.7% from $2.42 million a year earlier but up 4.1% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Share-based Compensation (IS) (2011 - 2017) Analysis & Trends
Over the trailing twelve months to Dec 31, 2017, Arrowhead Pharmaceuticals reported Share-based Compensation (IS) of $7.56 million, down 35.1% year-over-year; for FY2017 (ended Sep 30, 2017), it was $7.89 million, down 31.9% from FY2016.
- Share-based Compensation (IS) carries a five-year compound annual growth rate of 44.8% (FY2012 to FY2017).
- Going back by fiscal year, Share-based Compensation (IS) was $11.6 million in FY2016 (+13.3%), $10.23 million in FY2015 (+79.6%), $5.7 million in FY2014 (+270.8%) and $1.54 million in FY2013 (+23.8%).
- The five-year range for quarterly Share-based Compensation (IS) is $355,108 (fiscal Q2 2013) to $4.05 million (fiscal Q4 2016).
- Year-over-year, Share-based Compensation (IS) has declined for four consecutive quarters, with an average decline of 11.6% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation (IS) over five years came in fiscal Q4 2014 (growth of 731.8%), and the weakest in fiscal Q4 2017 (a decline of 50.4%).
- Business Quant data shows ARWR's Share-based Compensation (IS) at $2.01 million (Q4 2017), $1.71 million (Q3 2017) and $1.74 million (Q2 2017) in the three fiscal quarters before Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 8.36 Bn | 3.13 Bn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 2.09 Mn |
| Sep 30, 2017 | 2.01 Mn |
| Jun 30, 2017 | 1.71 Mn |
| Mar 31, 2017 | 1.74 Mn |
| Dec 31, 2016 | 2.42 Mn |
| Sep 30, 2016 | 4.05 Mn |
| Jun 30, 2016 | 2.75 Mn |
| Mar 31, 2016 | 2.42 Mn |
| Dec 31, 2015 | 2.38 Mn |
| Sep 30, 2015 | 3.53 Mn |
| Jun 30, 2015 | 2.49 Mn |
| Mar 31, 2015 | 2.21 Mn |
| Dec 31, 2014 | 2.01 Mn |
| Sep 30, 2014 | 3.51 Mn |
| Jun 30, 2014 | 1.07 Mn |
| Mar 31, 2014 | 1.20 Mn |
| Dec 31, 2013 | 521,138.00 |
| Sep 30, 2013 | 421,896.00 |
| Jun 30, 2013 | 363,593.00 |
| Mar 31, 2013 | 355,108.00 |
Arrowhead Pharmaceuticals Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();